Related Experiment Video
Updated: Jul 30, 2026

08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
13.2K
Functionalized Photoimmune Hydrogel Microspheres for Inside-Out Eradication of Osteosarcoma via a PD-L1 PROTAC
Huanhuan Luo1,2, Jun Ma2, Haiyang Yang2,3
1Central Laboratory, The Second Affiliated Hospital of Jiaxing University, Jiaxing, P. R. China.
Advanced Healthcare Materials
|November 22, 2025
Summary
This study introduces CP-MOF@gel, a novel immunogel microsphere for osteosarcoma treatment. It precisely degrades PD-L1 protein, reversing the immunosuppressive tumor microenvironment and enhancing immunotherapy outcomes.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
Background:
- Osteosarcoma immunotherapy is hindered by the immunosuppressive tumor microenvironment.
- Targeting PD-L1 is a key strategy to enhance anti-tumor immunity.
Purpose of the Study:
- To develop a novel immunogel microsphere (CP-MOF@gel) for precise PD-L1 protein degradation in osteosarcoma.
- To investigate the efficacy of CP-MOF@gel in reversing the immunosuppressive tumor microenvironment and enhancing immunotherapy.
Main Methods:
- Core-shell nanoparticles encapsulating Cypate and a PROTAC PD-L1 degrader (ppd) were synthesized.
- Microfluidic and photocuring techniques were used to create CP-MOF@gel.
- In vitro and in vivo studies assessed the system's drug release, ROS generation, photothermal effects, pyroptosis induction, and anti-tumor immunity.
Main Results:
- CP-MOF@gel demonstrated optimized synthesis for enhanced drug loading and reduced particle size.
- The system effectively released CP-MOFs, triggered pyroptosis, and induced photothermal effects upon irradiation.
- CP-MOF@gel significantly enhanced T-cell-mediated killing and improved immunotherapy outcomes in vivo.
Conclusions:
- CP-MOF@gel provides a precision PROTAC-based protein degradation strategy for osteosarcoma suppression.
- This 'inside-out' therapeutic approach effectively reverses the immunosuppressive tumor microenvironment.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

